Oslo Børs - Vedtatt overføring av notering fra Euronext Growth til Oslo Børs – Gentian Diagnostics ASA

23. Jun 2021 | 1 min read

Oslo Børs vedtok å ta aksjene i Gentian Diagnostics ASA opp til notering på Oslo
Børs.

Det forutsettes at selskapet før første noteringsdag oppfyller opptakskravene på
Oslo Børs.

Børsdirektøren gis fullmakt til å fastsette første noteringsdag, senest 22.
august 2021.


You may also read


Jun 25, 2021 - Kristin Hart

Gentian Diagnostics was today listed on the Oslo Stock Exchange

“We made a promise to our shareholders when we were listed on Euronext Growth that we would aim for the main..

Jun 24, 2021 - Kristin Hart

Gentian Diagnostics ASA – Approval and publication of prospectus, and transfer of listing from Euronext Growth (Oslo) to Oslo Børs

Moss, 24 June 2021 Reference is made to the announcement made by Gentian Diagnostics ASA (the "Company") on 7..

Jun 23, 2021 - Kristin Hart

Transfer of shares to Oslo Børs approved, prepared for accelerated growth

Moss, 23.06.2021 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of innovative and..